Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02822703 · ClinicalTrials.gov registry record · NA
Enhancing Relapse Prevention for Smoking Cessation With Repetitive Transcranial Magnetic Stimulation
A NA study of Smoking Cessation, sponsored by The City College of New York.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT02822703 is a NA study of Smoking Cessation that has completed, run by The City College of New York. The registered enrollment target is 29 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02822703, a NA study of Smoking Cessation, has completed, sponsored by The City College of New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
Tobacco use is one of the most significant cancer control and public health challenges in the US today. Half of all smokers in the US will attempt to quit tobacco each year, but fully 95% of those who attempt to quit will reverse this decision within 12 months and choose the transient, albeit immediately rewarding activity of smoking at the cost of much larger long-term rewards such as future health and long life. This project seeks to improve scientific knowledge of these decision-making processes and potentially improve the treatment of tobacco dependence by examining the feasibility of using a brain stimulation technique, repetitive Transcranial Magnetic Stimulation or rTMS to improve the efficacy of an existing evidence-based relapse prevention intervention. rTMS is an FDA-cleared treatment for medication resistant depression and is being examined as a treatment for a variety of other disorders. This study will utilize an intensity and duration of rTMS that is well within the safety parameters and similar in location and intensity to that used in previous studies with smokers to reduce cigarette consumption.
Conditions Studied
Interventions
- DEVICE rTMS Sham
- DEVICE rTMS Active 20Hz
Study Locations (1)
New York
- The City College of New York - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02822703
The ClinicalTrials.gov registry entry for NCT02822703 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (94% lower). The listed sponsor is The City College of New York, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which rTMS Sham is the first listed.
NCT02822703 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02822703 about?
NCT02822703 is a clinical study titled "Enhancing Relapse Prevention for Smoking Cessation With Repetitive Transcranial Magnetic Stimulation". Tobacco use is one of the most significant cancer control and public health challenges in the US today. Half of all smokers in the US will attempt to quit tobacco each year, but fully 95% of those who attempt to quit will reverse this decision within 12 months and choose the transient, albeit immedi...
What is the current status of trial NCT02822703?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2015-01. Estimated completion is 2016-06.
What conditions does trial NCT02822703 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT02822703?
The interventions under investigation include: rTMS Sham (DEVICE), rTMS Active 20Hz (DEVICE).
Who is sponsoring clinical trial NCT02822703?
This trial is sponsored by The City College of New York, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02822703 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.